Cook Enforcer Post-Market Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 211 participants.
Also called NCT03552289
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 211 participants
- Sponsor
- Registry
-
NCT03552289
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03552289. Randomized; no masking; primary purpose treatment. Start 2018-08-07 (actual); primary completion 2019-05-29 (actual). Results posted on 2020-08-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cook Enforcer Post-Market Study
- Condition
- End-Stage Renal Disease
- Intervention (Device)
- Cook Advance® Enforcer 35 Focal-Force Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter
- Intervention (Device)
- Conventional angioplasty balloon catheters
- Lead sponsor
- Cook Research Incorporated
Record details
- Record id
cardio:ct-nct03552289- Content hash
f1278b3f212ec020bef257bf2fe745b358b74afde1eba1b00bff65f8d33c25d1